Baxter International
About: Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Employees: 38,000
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
40% more call options, than puts
Call options by funds: $142M | Put options by funds: $102M
30% more first-time investments, than exits
New positions opened: 125 | Existing positions closed: 96
18% more capital invested
Capital invested by funds: $14.1B [Q4 2024] → $16.7B (+$2.59B) [Q1 2025]
17% more funds holding in top 10
Funds holding in top 10: 6 [Q4 2024] → 7 (+1) [Q1 2025]
2% more funds holding
Funds holding: 806 [Q4 2024] → 822 (+16) [Q1 2025]
0.37% more ownership
Funds ownership: 94.43% [Q4 2024] → 94.79% (+0.37%) [Q1 2025]
9% less repeat investments, than reductions
Existing positions increased: 271 | Existing positions reduced: 297
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$28
2%
downside
Avg. target
$34
18%
upside
High target
$42
46%
upside
4 analyst ratings
1 positive
25%
2 neutral
50%
1 negative
25%
Citigroup Joanne Wuensch | 12%upside $32 | Neutral Maintained | 9 Jul 2025 |
Evercore ISI Group Vijay Kumar | 46%upside $42 | Outperform Maintained | 8 Jul 2025 |
Morgan Stanley Patrick Wood | 2%downside $28 | Underweight Maintained | 5 May 2025 |
Wells Fargo Larry Biegelsen | 15%upside $33 | Equal-Weight Maintained | 2 May 2025 |
Financial journalist opinion
Based on 4 articles about BAX published over the past 30 days
Neutral
Investopedia
4 days ago
Medical Equipment Maker Baxter International Names New CEO
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
Neutral
Reuters
5 days ago
Baxter International Names Andrew Hider as CEO
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
Neutral
Business Wire
5 days ago
Baxter Appoints Andrew Hider Chief Executive Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independ.
Neutral
Business Wire
2 weeks ago
Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commitment to transparent reporting and provides updates on the company's 2030 Corporate Responsibility Commitment and Goals,1 which strive to create a more sustainable and responsible business model. “Baxter's Mission to Save and Sustain Lives inspires our work every day and has remained a guiding forc.
Neutral
GlobeNewsWire
1 month ago
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman Montana . The hotel needed a way to cool its event space while maintaining its historical charm.
Positive
24/7 Wall Street
1 month ago
3 Top Goldman Sachs Dividend Stock Picks Have Up to 73% Upside Potential
After a volatile stretch, yields in the Treasury bond market have stabilized. Concerns about the volatility in the bond and stock markets are leading investors to top-quality dividend stocks.
Neutral
Business Wire
1 month ago
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 10:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Sunday, December 7, 2025. About Baxter At Baxter, we are everywhere healthcare h.
Positive
Zacks Investment Research
1 month ago
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
Positive
24/7 Wall Street
1 month ago
4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks.
Neutral
Seeking Alpha
2 months ago
The 'Goldilocks' Case For Baxter International
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and management is optimistic toward 2025 performance.
Charts implemented using Lightweight Charts™